Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 6, 2006 - Issue 9
Submit an article Journal homepage
145
Views
14
CrossRef citations to date
0
Altmetric
Review

Innovations and recent trends in the treatment of ADHD

Vishal Madaan Resident in Child and Adolescent Psychiatry, Creighton University–University of Nebraska Medical Center, Omaha, NE, USA. [email protected]
,
Shannon Kinnan University of Nebraska Medical Center, Omaha, NE, USA. [email protected]
,
Joan Daughton Resident in Child and Adolescent Psychiatry, Creighton University–University of Nebraska Medical Center, Omaha, NE, USA. [email protected]
&
Christopher J Kratochvil Associate Professor, University of Nebraska Medical Center, Omaha, NE 68198–5581, USA. [email protected]
Pages 1375-1385 | Published online: 09 Jan 2014

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Brigette Vaughan, Joerg Fegert & Christopher J Kratochvil. (2009) Update on atomoxetine in the treatment of attention-deficit/hyperactivity disorder. Expert Opinion on Pharmacotherapy 10:4, pages 669-676.
Read now
Joshua M Langberg, Tanya E Froehlich, Richard EA Loren, Jessica E Martin & Jeffery N Epstein. (2008) Assessing children with ADHD in primary care settings. Expert Review of Neurotherapeutics 8:4, pages 627-641.
Read now

Articles from other publishers (12)

Austin W. Blum & Jon E. Grant. 2020. The Cambridge Handbook of Substance and Behavioral Addictions. The Cambridge Handbook of Substance and Behavioral Addictions 373 385 .
. 2020. The Cambridge Handbook of Substance and Behavioral Addictions. The Cambridge Handbook of Substance and Behavioral Addictions 295 425 .
. 2020. The Cambridge Handbook of Substance and Behavioral Addictions. The Cambridge Handbook of Substance and Behavioral Addictions.
Ali Ghaleiha, Mohammad Ghyasvand, Mohammad-Reza Mohammadi, Mehdi Farokhnia, Noorollah Yadegari, Mina Tabrizi, Reza Hajiaghaee, Habibeh Yekehtaz & Shahin Akhondzadeh. (2013) Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial. Journal of Psychopharmacology 28:7, pages 677-685.
Crossref
Brigette Vaughan & Christopher J. Kratochvil. (2012) Pharmacotherapy of Pediatric Attention-Deficit/Hyperactivity Disorder. Child and Adolescent Psychiatric Clinics of North America 21:4, pages 941-955.
Crossref
Brigette S. Vaughan, John S. March & Christopher J. Kratochvil. 2012. Essential Evidence-Based Psychopharmacology. Essential Evidence-Based Psychopharmacology 1 17 .
Brigette S. Vaughan, John S. March & Christopher J. Kratochvil. (2011) The evidence-based pharmacological treatment of paediatric ADHD. The International Journal of Neuropsychopharmacology 15:01, pages 27-39.
Crossref
Brigette S. Vaughan, Holly J. Roberts & Howard Needelman. (2009) Current medications for the treatment of Attention-Deficit/Hyperactivity Disorder. Psychology in the Schools 46:9, pages 846-856.
Crossref
Christopher J. Kratochvil, Brigette S. Vaughan, Amy Barker, Lindsey Corr, Ashley Wheeler & Vishal Madaan. (2009) Review of Pediatric Attention Deficit/Hyperactivity Disorder for the General Psychiatrist. Psychiatric Clinics of North America 32:1, pages 39-56.
Crossref
Francisco López-Muñoz, Cecilio Alamo, Francisco Javier Quintero-Gutiérrez & Pilar García-García. (2008) A bibliometric study of international scientific productivity in attention-deficit hyperactivity disorder covering the period 1980–2005. European Child & Adolescent Psychiatry 17:6, pages 381-391.
Crossref
Johnny Graham & David Coghill. (2008) Adverse Effects of Pharmacotherapies for Attention-Deficit Hyperactivity Disorder. CNS Drugs 22:3, pages 213-237.
Crossref
Samuel R. Chamberlain, Natalia del Campo, Jonathan Dowson, Ulrich Müller, Luke Clark, Trevor W. Robbins & Barbara J. Sahakian. (2007) Atomoxetine Improved Response Inhibition in Adults with Attention Deficit/Hyperactivity Disorder. Biological Psychiatry 62:9, pages 977-984.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.